Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-21

FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (KVK-TECH, INC.)

View source ↗

Summary

FDA approved a supplemental application for methylphenidate hydrochloride from KVK-Tech, Inc., a generic stimulant used to treat attention-deficit/hyperactivity…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)